摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

11-Chloro-1-oxo-1H,8H-4,7a,12b-triaza-dibenzo[e,g]azulene-2-carboxylic acid ethyl ester | 99390-36-0

中文名称
——
中文别名
——
英文名称
11-Chloro-1-oxo-1H,8H-4,7a,12b-triaza-dibenzo[e,g]azulene-2-carboxylic acid ethyl ester
英文别名
Ethyl 11-chloro-15-oxo-6,14,18-triazatetracyclo[12.4.0.02,6.08,13]octadeca-1(18),2,4,8(13),9,11,16-heptaene-16-carboxylate
11-Chloro-1-oxo-1H,8H-4,7a,12b-triaza-dibenzo[e,g]azulene-2-carboxylic acid ethyl ester化学式
CAS
99390-36-0
化学式
C18H14ClN3O3
mdl
——
分子量
355.78
InChiKey
MKWKILTYRWGATM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    63.9
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    1-(4-Chloro-2-nitro-benzyl)-1H-pyrrole-2-carbonitrile 在 palladium on activated charcoal 氢气苄基三甲基氢氧化铵 作用下, 以 甲醇甲苯 为溶剂, 25.0~278.0 ℃ 、101.33 kPa 条件下, 反应 8.5h, 生成 11-Chloro-1-oxo-1H,8H-4,7a,12b-triaza-dibenzo[e,g]azulene-2-carboxylic acid ethyl ester
    参考文献:
    名称:
    新型咪唑并[1,2- a ]吡咯并[2,1- c ] [1,4]苯并二氮杂和嘧啶基[1,2- a ]吡咯并[2,1- c ] [1,4]苯并二氮杂的合成
    摘要:
    几种1 1-氨基-5 H-吡咯并[2,1- c ] [1,4]苯并二氮杂已用作起始原料,以制备9 H-咪唑并[ 1,2- a ]吡咯并[2]的许多衍生物。,1- c ] [1,4]苯并二氮杂和10 H-嘧啶基[1,2- a ]吡咯并[2,1- c ] [1,4]苯并二氮杂。咪唑核是通过am与溴丙酮酸乙酯或氨基乙醛二甲基缩醛反应而构建的。咪唑并[1,2- a ]吡咯并[2,1- c ] [1,4]苯并二氮杂卓的几种衍生物已经通过吡咯环的甲酰化反应,然后形成硫代酰胺来制备。11-氨基-5 H-吡咯并[2,1-的缩合c ] [1,4]苯并二氮杂卓与乙氧基亚甲基丙二酸二乙酯提供中间体二酯,将其转化为相应的10 H-嘧啶基[1,2- a ]吡咯并[2,1- c ]-苯并二氮杂卓。
    DOI:
    10.1002/jhet.5570220214
点击查看最新优质反应信息

文献信息

  • DUCEPPE, J. -S.;GAUTHIER, J., J. HETEROCYCL. CHEM., 1985, 22, N 2, 305-310
    作者:DUCEPPE, J. -S.、GAUTHIER, J.
    DOI:——
    日期:——
  • Synthesis of novel imidazo[1,2-<i>a</i>]pyrrolo[2,1-<i>c</i>][1,4]benzodiazepines and pyrimido[1,2-<i>a</i>]pyrrolo[2,1-<i>c</i>][1,4]benzodiazepines
    作者:Jean-Simon Duceppe、Jean Gauthier
    DOI:10.1002/jhet.5570220214
    日期:1985.3
    1-amino-5H-pyrrolo[2,1-c][1,4]benzodiazepines have been used as starting material to prepare a number of derivatives of 9H-imidazo[1,2-a]pyrrolo[2,1-c][1,4]benzodiazepines and 10H-pyrimido[1,2-a]pyrrolo[2,1-c][1,4]benzodiazepines. The imidazole nucleus was built by reaction of amidines with ethyl bromopyruvate or aminoacetaldehyde dimethylacetal. Several derivatives of imidazo[1,2-a]pyrrolo[2,1-c][1,4]benzodiazepine
    几种1 1-氨基-5 H-吡咯并[2,1- c ] [1,4]苯并二氮杂已用作起始原料,以制备9 H-咪唑并[ 1,2- a ]吡咯并[2]的许多衍生物。,1- c ] [1,4]苯并二氮杂和10 H-嘧啶基[1,2- a ]吡咯并[2,1- c ] [1,4]苯并二氮杂。咪唑核是通过am与溴丙酮酸乙酯或氨基乙醛二甲基缩醛反应而构建的。咪唑并[1,2- a ]吡咯并[2,1- c ] [1,4]苯并二氮杂卓的几种衍生物已经通过吡咯环的甲酰化反应,然后形成硫代酰胺来制备。11-氨基-5 H-吡咯并[2,1-的缩合c ] [1,4]苯并二氮杂卓与乙氧基亚甲基丙二酸二乙酯提供中间体二酯,将其转化为相应的10 H-嘧啶基[1,2- a ]吡咯并[2,1- c ]-苯并二氮杂卓。
查看更多

同类化合物

阿斯普尼辛B 阿斯普尼辛 D 阿斯普尼辛 苯佐莫文 新骏河毒素 乙酰胺,N-(4-硝基-2-吡啶基)-,氧化(9CI) TAK960抑制剂 PLK1抑制剂(RO3280) 8H-嘧啶并[4,5-b][1,4]二氮杂卓 8-甲基-5,9-二氢-6H-嘧啶并[4,5-b][1,4]重氮基庚英-6-酮 6H-嘧啶并[4,5-b][1,4]二氮杂卓 4-甲基-6,11-二氢-3H-嘧啶并[4,5-b][1,5]苯并二氮杂卓-2,5-二酮 2-氯-7,7-二氟-5-甲基-5,7,8,9-四氢-6H-嘧啶基[4,5-B][1,4]二氮杂-6-酮 2-氯-5-甲基-5,7,8,9-四氢-6H-嘧啶[4,5-B][1,4]二氮杂6-酮 1H-嘧啶并[4,5-b][1,4]二氮杂卓 4-amino-8-(1,3-benzodioxol-5-yl)-6-phenyl-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepine 2-(2-Bromo-4-isopropyl-phenyl)-4-methyl-6-pentyl-6,7,8,9-tetrahydro-2H-2,3,5,6,9a-pentaaza-benzo[cd]azulen-1-one 2-chloro-8-(trifluoromethyl)-6H,11H-benzo[b]pyrimidino[5,4-f]-1,4-diazaperhydroepin-5-one 4,5,6,7-tetrahydro-2,4-diphenyl-4,7a,12b-triazadibenzo[e,g]azulene-1,3,8-trione 4,5,6,7-tetrahydro-4-methyl-2-phenyl-4,7a,12b-triazadibenzo[e,g]azulene-1,3,8-trione N-(4-((8,9-dimethoxy-5-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-11H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-5-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6-oxo-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-fluorophenyl)-N-(4-((8-methoxy-2-methyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6-oxo-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-fluorophenyl)-N-(4-((8-methoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-11H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-((8,9-dimethoxy-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide di-tert-butyl (1r,4r)-4-(4-(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxybenzamido)cyclohexyl phosphate 2-(2-Bromo-4-isopropyl-phenyl)-6-(1-ethyl-propyl)-4-methyl-6,7,8,9-tetrahydro-2H-2,3,5,6,9a-pentaaza-benzo[cd]azulen-1-one 7,8,9,10-tetrahydro-10-hydroxy-9-heptyl-[1,4]diazepino[1,2,3-g,h]purine 7,8,9,10-tetrahydro-10-hydroxy-9-methyl-9-propyl[1,4]diazepino[1,2,3-g,h]purine 6-cyclopentyl-9-[(3-methoxyphenyl)amino]-2-methyl-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-3-one 6-cyclopentyl-9-[(2-methoxyphenyl)amino]-2-methyl-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-3-one tert-butyl 8,10-dibromo-7-oxo-1,2,5,5a,6,7-hexahydro-[1,4]diazepino[1,7-a]quinazoline-3(4H)-carboxylate tert-butyl 8,10-dimethyl-7-oxo-1,2,5,5a,6,7-hexahydro-[1,4]diazepino[1,7-a]quinazoline-3(4H)-carboxylate 11-Diallylaminoacetyl-6-isopropyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 6-butyl-11-diallylaminoacetyl-2-phenyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 11-chloroacetyl-6-isopropyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one 4-[(2-cyclopentyl-4,4,6-trimethyl-5-oxo-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-10-yl)amino]benzoic acid 4-[(2-cyclopentyl-6-methyl-5-oxo-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-10-yl)amino]-3-methoxy-N-(4-piperidyl)benzamide 4-[(6-cyclopentyl-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl)amino]-N-(1-ethyl-4-piperidyl)-3-methoxy-benzamide 8-(4-chlorophenyl)-6-phenyl-9H-pyrimido[4,5-b][1,4]diazepin-4-ol 1-chloro-7-methoxy-8-(3-morpholin-4-yl-propoxy)-10,11-dihydro-5H-2,4,5,11-tetraaza-dibenzo[a,d]cycloheptene 4-[(6-cyclopentyl-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl)amino]-3-methoxy-N-methyl-benzamide (S)-tert-butyl (4-chloro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-7-yl)carbamate 3-methoxy-4-[[6-(2-methoxyethyl)-2-methyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl]amino]-N-(1-methyl-4-piperidyl)benzamide (9aS,9R)-4-chloro-N-(4-methylphenyl)-9a,10,11,12-tetrahydro-9H-pyrimido[4,5-b]dipyrrolo[1,2-d:2',1'-g][1,4]diazepin-9-amine